Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Selling business ideas successfully requires strategic planning and effective communication. Explore actionable tips to enhance your selling skills.
17,434 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
OpenAI CEO Sam Altman says AI could someday run a major company better than its human leadership, a warning that coul...
NVIDIA is set to report fiscal Q4 2026 results after the close on February 25, 2026. Street expectations point to a b...
Explore how Invitation Homes navigated Q4 2025, the drivers behind its earnings, and what savvy investors should watc...
Billionaire investor Mark Cuban argues the current economics of AI agents create a meaningful short-term counter to j...
Detroit automakers request tariff relief from the White House as a universal levy looms, citing rising costs and supp...
Investors chasing income with growth potential often look for a reliable pillar. This elite 5.5%-yielding dividend of...
IBM's shares sank as Anthropic's Claude Code intensifies AI competition, pushing ibm’s stock heads worst for a month ...
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
NVIDIA is set to report after the close as investors weigh Amazon’s $200 billion 2026 capex plan. The move reframes r...
Dreaming of easy flights and hotel stays? Credit cards with bonus travel points offers can unlock big-value redemptio...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...